Loading...
Loading...
Among the 8 tracked institutional investors we monitor, BCRX (BIOCRYST PHARMACEUTICALS INC) is held with a combined value of $539.68M across 60,713,566 shares. The largest holder is BlackRock, Inc. with a position worth $215.64M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$539.68M
Total Shares Held
60,713,566
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $215.64M | 0.00% | +7.2% |
| 2 | VANGUARD GROUP INC | $173.73M | 0.00% | New |
| 3 | STATE STREET CORP | $116.22M | 0.00% | +10.3% |
| 4 | CITADEL ADVISORS LLC | $11.57M | 0.00% | -19.7% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $7.40M | 0.01% | -63.5% |
| 6 | Bridgewater Associates, LP | $6.07M | 0.03% | +170.9% |
| 7 | FMR LLC | $6.03M | 0.00% | +13.0% |
| 8 | MILLENNIUM MANAGEMENT LLC | $3.02M | 0.00% | +130.9% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of BCRX with a position worth $215.64M, representing 0.00% of their portfolio. In total, 8 institutional investors hold BCRX with a combined value of $539.68M.
In the most recent quarter, 1 fund opened a new position in BCRX. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $539.68M worth of BCRX stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $215.64M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For BCRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their BCRX positions.